Scientific Opinion on Ergot alkaloids in food and feed

<p>The European Food Safety Authority (EFSA) was asked by the European Commission to deliver a scientific opinion on ergot alkaloids (EAs) in food and feed. EAs are produced by several members within the fungal orders of Hypocreales and Eurotiales. In Europe, <em>Clavicep...

Full description

Bibliographic Details
Main Author: EFSA Panel on Contaminants in the Food Chain
Format: Article
Language:English
Published: Wiley 2012-07-01
Series:EFSA Journal
Subjects:
Online Access:http://www.efsa.europa.eu/en/efsajournal/doc/2798.pdf
_version_ 1818600155337719808
author EFSA Panel on Contaminants in the Food Chain
author_facet EFSA Panel on Contaminants in the Food Chain
author_sort EFSA Panel on Contaminants in the Food Chain
collection DOAJ
description <p>The European Food Safety Authority (EFSA) was asked by the European Commission to deliver a scientific opinion on ergot alkaloids (EAs) in food and feed. EAs are produced by several members within the fungal orders of Hypocreales and Eurotiales. In Europe, <em>Claviceps purpurea</em> is the most widespread <em>Claviceps</em> species within the Hypocreales. A total of 20 558 analytical results for EAs in 1 716 food, 496 feed and 67 unprocessed grain samples were considered in this opinion. Based on the EAs identified in sclerotia of <em>C. purpurea</em>, and recent literature data, the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) based its risk assessment on the main <em>C. purpurea</em> EAs, namely ergometrine, ergotamine, ergosine, ergocristine, ergocryptine (which is a mixture of α- and β- isomers), ergocornine, and the corresponding –inine epimers. The CONTAM Panel performed estimates of both chronic and acute exposure for various age groups across European countries. A BMDL<sub>10</sub> of 0.33 mg/kg b.w. per day was calculated for the incidence of tail muscular atrophy in a 13-week rat feeding study of ergotamine. This effect was considered representative of the vasoconstrictive effects of EAs and provided a suitable reference point for establishment of a group acute reference dose of 1 μg/kg body weight (b.w.) and a group tolerable daily intake of 0.6 μg/kg b.w. per day. The Panel concluded that whilst the available data do not indicate a concern for any population subgroup, the dietary exposure estimates relate to a limited number of food groups and a possible unknown contribution from other foods cannot be discounted. Estimates of exposure for livestock based on example diets and levels of EAs in cereal grains reported suggest that under normal conditions the risk of toxicosis is low.</p>
first_indexed 2024-12-16T12:30:59Z
format Article
id doaj.art-867662aa0cf641e487b0ca93b7f0b235
institution Directory Open Access Journal
issn 1831-4732
language English
last_indexed 2024-12-16T12:30:59Z
publishDate 2012-07-01
publisher Wiley
record_format Article
series EFSA Journal
spelling doaj.art-867662aa0cf641e487b0ca93b7f0b2352022-12-21T22:31:42ZengWileyEFSA Journal1831-47322012-07-0110710.2903/j.efsa.2012.2798Scientific Opinion on Ergot alkaloids in food and feedEFSA Panel on Contaminants in the Food Chain<p>The European Food Safety Authority (EFSA) was asked by the European Commission to deliver a scientific opinion on ergot alkaloids (EAs) in food and feed. EAs are produced by several members within the fungal orders of Hypocreales and Eurotiales. In Europe, <em>Claviceps purpurea</em> is the most widespread <em>Claviceps</em> species within the Hypocreales. A total of 20 558 analytical results for EAs in 1 716 food, 496 feed and 67 unprocessed grain samples were considered in this opinion. Based on the EAs identified in sclerotia of <em>C. purpurea</em>, and recent literature data, the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) based its risk assessment on the main <em>C. purpurea</em> EAs, namely ergometrine, ergotamine, ergosine, ergocristine, ergocryptine (which is a mixture of α- and β- isomers), ergocornine, and the corresponding –inine epimers. The CONTAM Panel performed estimates of both chronic and acute exposure for various age groups across European countries. A BMDL<sub>10</sub> of 0.33 mg/kg b.w. per day was calculated for the incidence of tail muscular atrophy in a 13-week rat feeding study of ergotamine. This effect was considered representative of the vasoconstrictive effects of EAs and provided a suitable reference point for establishment of a group acute reference dose of 1 μg/kg body weight (b.w.) and a group tolerable daily intake of 0.6 μg/kg b.w. per day. The Panel concluded that whilst the available data do not indicate a concern for any population subgroup, the dietary exposure estimates relate to a limited number of food groups and a possible unknown contribution from other foods cannot be discounted. Estimates of exposure for livestock based on example diets and levels of EAs in cereal grains reported suggest that under normal conditions the risk of toxicosis is low.</p>http://www.efsa.europa.eu/en/efsajournal/doc/2798.pdfErgot alkaloids (EAs)originchemistryanalysisexposurerisk assessmenthealth-based guidance value
spellingShingle EFSA Panel on Contaminants in the Food Chain
Scientific Opinion on Ergot alkaloids in food and feed
EFSA Journal
Ergot alkaloids (EAs)
origin
chemistry
analysis
exposure
risk assessment
health-based guidance value
title Scientific Opinion on Ergot alkaloids in food and feed
title_full Scientific Opinion on Ergot alkaloids in food and feed
title_fullStr Scientific Opinion on Ergot alkaloids in food and feed
title_full_unstemmed Scientific Opinion on Ergot alkaloids in food and feed
title_short Scientific Opinion on Ergot alkaloids in food and feed
title_sort scientific opinion on ergot alkaloids in food and feed
topic Ergot alkaloids (EAs)
origin
chemistry
analysis
exposure
risk assessment
health-based guidance value
url http://www.efsa.europa.eu/en/efsajournal/doc/2798.pdf
work_keys_str_mv AT efsapaneloncontaminantsinthefoodchain scientificopiniononergotalkaloidsinfoodandfeed